{"ticker": {"uuid": "7ce80b93-96c5-4bc7-b90b-145384feed36", "symbol": "600196", "name": "Shanghai Fosun Pharmaceutical (Group) Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Fosun Pharma stock holds firm as revenue grows and R&D spending rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNek5sLWtLLXo1VGtmZHU1eGVLTk1wX1NoZklid3dJZGhqeElOa0Z4SU5wSU5wWnA1UmlnU1N3VFNlcGlzZGQ2QkVGX19ubVVrVEt1ZTVVam9wUEFhdVVnQWJJU2UwOE9LSlNybWdtN19EMTg0bG1wSXk3STcyMGpsX1BuWml0RGE2aHBwMGF1SlZST3k1THpwNDA1VkQtS3BudTdvejdSdVAtblNad3QzeC1vakUxc2hwLVpjR2twVFpQSFQzMWtnNE1mQl8?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-19T20:10:39+00:00", "published_display": "19 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma (600196.SH) 2025 Annual Dividend Distribution: CNY 0.39 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOZ3ZhdllxNlhhY0t1aEY4NU5wODFRd3dVdHpGaG1qN0lldHV3VGZNOXFnVXl4U0djRzIyNFNicHY1dzlEaWFOTDZBdEZNbUlkdXdDcmZWM0haQXc3b1FOX1BuTXpneXM5WU5zUWE0ZklGQ2p1S3M1UENYaHBiaDRBc2M5LXZIdGZlczRpMzFENFZOWDlwaEFtUXRvd2NVOVV5ZGNFTzZB?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-16T08:30:55+00:00", "published_display": "16 Jul 2026 08:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma (600196.SH): A drug developed by its majority-owned subsidiary has received approval to commence clinical trials.", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOWDR3NV84TkppQXRyb0dsVmdqTU1HbDZSN3M5U2hGVGxsYndGa1VkZktUb1V6bkRGdjBDOWlZbTFEemNoMDh4cXNfS3hkcE01T0tHZzByNjRlR0c1T3JrTHlzdnhuMUJfWWtMYXNnNVJuZXQ2MFZUMjVtbmlyRXFWZjVtZEt5b0U1STJvbU44ZzJQSzdfQ19YcGZESFM?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-10T08:47:22+00:00", "published_display": "10 Jul 2026 08:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Han Qu You from Shanghai Fosun Pharmaceutical Co. - trastuzumab biosimilar targets HER2-positive can", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOczlVNU5CRW5NRE9JUjhGZzAzWGtRS0ZJSUN5RVd4b3MxQU5OclctSlBsd2RSLTJIZFVfbEd1ZzdGelRpOHdnem9fM0M1eGEzSmM5U3FfU1RVcG5tc05QamFTdHh6ZDlFV0hQckZKS01tNVl3ancyUFl2WjZ1OXNOZVZhdExwV1lfMmlBWFV1d05lTnQtc1lHTzdsdEU5b3BVRjFKU3BUQTRwZUNsNnpZdnpUVm55cDJaZVUwckhLQzNCVjhVZF9KeFFR?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-30T04:27:39+00:00", "published_display": "30 Jun 2026 04:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma Stock - analyst consensus and technical picture on a quiet news day", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOeEQtMXM5VUQyaGNxVkppZTRBS1ptUTlHVjRhY2JabGhfejQ4TTY1cUpNMnJ6aEo1S0VDZVF1a3c3VDVUd1NaOWNLMGxNOHVjRXlfd2Zkb0tyaExHSkxxT0JvSDJIVzBlS2x0MndrcTBzLU1vMTJKTDFFNVFDc0pQWE1pOXNucGpITG5CSFdRdlpseEhiU09uSzF2Q2JUOEk4MEF2QW9nVUppZzJpdjEtN1RlemRCT3FIN3pXZ1ZUaWVfbnZvUU1n?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-18T20:53:13+00:00", "published_display": "18 Jun 2026 20:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun secures rights to Aribio\u2019s AR-1001 in potential $4.7B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVDdlMzFlMjA2VHJHVFgwa1puTDJCWE1mY3ZiWXlCbnlvRm4xVXVzUTFBOFJkcUVLWnZTOEtNUGdCZmJLOGVmR3lCRld5cGF1ZjdNWlNudE9tOFc1RTRmakRkZ2ZHWXdVcnhFamc2WFBlUTF5WkVuNHBqTnFtc3R2NXhSSkg3TlFRa0RMbGhyV1dOdTZPQmtDSnVUMzk1UDg2QUJxNw?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNSVdiamVsSDVJVGxVckFWV09xTFBjSE1KTFJwdDFUVThXUjZHczFBQ1d4Z3FhOGZCTXY2SjhacEpvQVlOMHdpQWxsZlE1VHdRWVB1TGJETHpOLWVQWHBUcmJsVXZ5WTRKc20tWkp6NnlXdGRyZUpOZERMZ013Y0ljdUNLMG9LOU0waVQ0LVRiX1oyVmlqT2xvRHp6RHV5Z0lCV09QUVp2NGllaEFydEFpMWh5TThLcl9iNy16ZEdONVNCdVliam9vdUJBek1wcDJ0NmNPSFZDTjhkZHo3QmtBUDdSakNLQVZC?oc=5", "source_name": "BioSpace", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Fosun Pharma eyes spin-off Hong Kong IPO of vaccine unit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma Inks Deal to Revive Botched China Alzheimer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPeHhraXd4RzZOUG9kNXg0YTRtNHFtNi1ROEN3T01LNDRwbXBJYXlJZEphUWFIaUFTRnN1VWhTV3JQTVhUMW1mbU5LTERCZFVZWFBqVW04UkN4alNPXzI5VjMzNVFtT0QwVHRtYlVZMkxHVVVGNTZwWjQtMHRLbWVyRkVXMzFIaTR3VlF1X3FBUDh4ZENyclJtVDFjSHBwNDZXUUFnMGM0U2hYRHAzSUE?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun out-licenses phase II DPP-1 to newco Expedition for $645M", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2V0VElQcHUtUGpnSl9rcF9NSXRTNURjclVVa2VSZ0dnM2ZJNzU5WFViSHpmaTU1SjViakQteFR2Q1ZjSFNMY2JKWENkcDY3UmtnMWFUR2VEenNzaFltUEctaFdHOXJpQl92VHc4WG0xS1oya2JVTm9PN0twUE9Nd25CLVpXeS1WZVhkV0tYS1gtUFNPS1NGODI5OEROS25xcnJZV3B3?oc=5", "source_name": "BioWorld News", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Henlius Biotech shareholders reject take-private offer from China's Fosun", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNQzNvVGlEUTRheEp4RGFvTUdkYzI0ZmRhUUZJRFV5TFlxV1dFSkt3a2d0NWZwRTRCd0ZTcjZTVG1CNUE1NHZCSkJtSFVVUmcwY2QwaTNOcVZPRExBeW9sanhrT2RHZ0hUcldhU1pYRlNXRGplWjlZSGVzN2RvR0dZU0hkLW14Z1VRcVFCLURqUE11LXlvOWZTTXBld29XUnZubDdkLW5BYzVBVWxEejJFYVR0U1BzWmJ3VXVGa1FTMDNTZ0JrQzlmX2NXbGlGYURWZDJWaWFn?oc=5", "source_name": "Reuters", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun's proposed Henlius Biotech buyout fails to pass shareholder vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZDI0dVRmVGtRMVNlMHJDNWRaSThwejRYWnFjc3NSUExjZmJLc3JYTFhtdmNXd2xocTRPS1lJdEIzenJVTHF3VFhWTlNaSml3NmxneDlkd0FUdGtVeHUzZ2hMMDhaTld5YjhsbURZRkVPUGpVTEJndjc0Uk5ydXptbTYtMDdMVl9KeTgzSE00M1VxTzRqZXAzalBwajdFUlBKLUF0Mzk5eXNXYjlwVlE?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma Offers $692 Million to Privatize Innovative Drugmaker Henlius", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPSUNURDBHckp3T0toMWtUMHNURE5zNHBzWS1ZQ3J5YjdmeFlFNWVLNkZxbDhJekFDaTlQTHBrWEhRQUdUdzZYTXVCbE9XOGQ1ZTBoSENaUldBd1pkWThCaVAtMEpmZklwaHo2a29lemdBNHlHSVAtQ28xakxDcnZIQW5KLTBQREh6QXpQZUJ0Q0hIaG56SGpobTdsOFM1eVRzUmlCZFlGSklSYWRIYjdINU5SZG1DYTItN3hwMDc3S3pNNG1WZTZN?oc=5", "source_name": "Caixin Global", "published_at": "2024-06-26T07:00:00+00:00", "published_display": "26 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma soars after Beijing accepts application for vaccine trial", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2020-07-14T07:00:00+00:00", "published_display": "14 Jul 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China approves its first biosimilar, a Rituxan copy from Fosun\u2019s IPO-heading Henlius", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTFQ3aVQzRUlKanlLMjFLU3o4ZkpOaTJhLTk0VnVZVy1RN2hOQmJNNTZGcjE3X3cwNlcyOC00VEhJaHplOGVNNXZMajF6U1ItQWR1SHR2emdWMFFPbUZzZUhTbDhmVzFaRVJkaGZuNmJhVUxZNE5OVUM5V05PSlZGWklSLWJ0LVhiWVhRczJKREVSR3lQbUpBRUhxbG5SRnh2V1lkX29ObUNjdHFrNWtXaDZWcjlETnNQSExrR1N4SQ?oc=5", "source_name": "Fierce Pharma", "published_at": "2019-02-25T08:00:00+00:00", "published_display": "25 Feb 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Fosun Pharma to buy French drug distributor Tridem", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2017-10-30T07:00:00+00:00", "published_display": "30 Oct 2017 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Fosun, Shanghai Pharma say bid for stake in U.S. drug maker Arbor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxORE1nRWEzS2x4U29fX3NVZWMwN1R2dURrY0JvbWNMTkgzUzdFSVFqNll6SmhoV2ZpMGkwV01raXE3LWtaWkluSV84cjF3VDExLXY0bXowM1VyV29DX0xITEdnTUV2VmJ3eXZsTlJzQUZtTkpubWJ4QkJxb2duaGF6M19tcGZwQTlFVjRoZnNhOUR0YVd1Q1IyalpSTndVV0Q2NnQwZ3VPMFdBZ9IBrwFBVV95cUxOLWdybE1qQmNrazhvZEpfOEFCQVlTdVNmQ2cweU5KNzFTSy0tNEFXeTVnclNIcDNvc19NTjRhd1pGVlA4d2N1QTFwS0w3MmhPMDBMNGJMSktfTkFSclBrdVNyVklwTloxRnhDdkFqREp6LWEyVTF4Q1VYUi1RRlhNRmxEOEc1QTVvb2pEc2dFd0s1aVNWYUpPNl8xNzVuamVEQ1VqY2pmWEFJbnZhZWtR?oc=5", "source_name": "CNBC", "published_at": "2017-08-14T07:00:00+00:00", "published_display": "14 Aug 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun stock tumbles over rumors of chairman disappearance\u2014again", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPMXI3UU11REFJcUhRVGl4TlF0QUJ1V2syeG9BdDdKRHpMWk11LXN5MER1RWN4S29CRUdxcndzRXdiOUp0TkI3a3V1OGdrS0NndnJJZHp3cllFWWF3VTNGaTdlNEVNeEJ2QTZXak1aQVZUVmNoNElhTHJpbXU0Q25lbHV3MThOemFHdnlmSDhuX2tKdFRhTjJfNzVLcVBfaWVWeVJz?oc=5", "source_name": "Fierce Pharma", "published_at": "2017-07-07T07:00:00+00:00", "published_display": "07 Jul 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Group attempts to explain as high-profile chief detained by China authorities", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMDdBcFNMMklROEgxSEFLN0dPMld4Y1ctTFoxbDh5SnFCaWxOUjJCVUhONHMxNDBXbXJaR0luRVdzVnZhWFZ6MmZJTTh1V1NROFNqdFhFZ3RENVE5Z1pNc1F1MXh1MGVYNDJmVVRNdVBIdi14QWN0SEYtWC1mNExIUlpLTklIaW9JNmF4QXIzZDM1NUpuNGRCUHd1czlqc0lCa2lydmhobHFRNzVWS09CZGw0ajhUZ3VKTWpITV9oN2Q?oc=5", "source_name": "Fierce Pharma", "published_at": "2015-12-14T08:00:00+00:00", "published_display": "14 Dec 2015 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chindex To Merge With Fosun Pharma At Higher Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPUzcyVTFNMmVaQkNoRERUSHV5dUJBTHN0Q0FQZ1N5cGZfS1VfX0pDbGpETGc1NEFHSm84Q1RBT3k4NGQ3S25vcmV2eG92QjNfdG1mYmxmQ1FyUG1UQXd6SnhhRG80Y0FXLWl3MGxudkFBODFDdVljc2ZJUWxhRHF4NW5tOEtHTzdZRlc1QUhuQ3hSSldKR3gxU1FCeHo3UQ?oc=5", "source_name": "Asian Scientist Magazine", "published_at": "2014-05-05T07:00:00+00:00", "published_display": "05 May 2014 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Fosun Pharma stock holds firm as revenue grows and R&D spending rises", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNek5sLWtLLXo1VGtmZHU1eGVLTk1wX1NoZklid3dJZGhqeElOa0Z4SU5wSU5wWnA1UmlnU1N3VFNlcGlzZGQ2QkVGX19ubVVrVEt1ZTVVam9wUEFhdVVnQWJJU2UwOE9LSlNybWdtN19EMTg0bG1wSXk3STcyMGpsX1BuWml0RGE2aHBwMGF1SlZST3k1THpwNDA1VkQtS3BudTdvejdSdVAtblNad3QzeC1vakUxc2hwLVpjR2twVFpQSFQzMWtnNE1mQl8?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-19T20:10:39+00:00", "published_display": "19 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma (600196.SH) 2025 Annual Dividend Distribution: CNY 0.39 per share", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOZ3ZhdllxNlhhY0t1aEY4NU5wODFRd3dVdHpGaG1qN0lldHV3VGZNOXFnVXl4U0djRzIyNFNicHY1dzlEaWFOTDZBdEZNbUlkdXdDcmZWM0haQXc3b1FOX1BuTXpneXM5WU5zUWE0ZklGQ2p1S3M1UENYaHBiaDRBc2M5LXZIdGZlczRpMzFENFZOWDlwaEFtUXRvd2NVOVV5ZGNFTzZB?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-16T08:30:55+00:00", "published_display": "16 Jul 2026 08:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma (600196.SH): A drug developed by its majority-owned subsidiary has received approval to commence clinical trials.", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOWDR3NV84TkppQXRyb0dsVmdqTU1HbDZSN3M5U2hGVGxsYndGa1VkZktUb1V6bkRGdjBDOWlZbTFEemNoMDh4cXNfS3hkcE01T0tHZzByNjRlR0c1T3JrTHlzdnhuMUJfWWtMYXNnNVJuZXQ2MFZUMjVtbmlyRXFWZjVtZEt5b0U1STJvbU44ZzJQSzdfQ19YcGZESFM?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-10T08:47:22+00:00", "published_display": "10 Jul 2026 08:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Han Qu You from Shanghai Fosun Pharmaceutical Co. - trastuzumab biosimilar targets HER2-positive can", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOczlVNU5CRW5NRE9JUjhGZzAzWGtRS0ZJSUN5RVd4b3MxQU5OclctSlBsd2RSLTJIZFVfbEd1ZzdGelRpOHdnem9fM0M1eGEzSmM5U3FfU1RVcG5tc05QamFTdHh6ZDlFV0hQckZKS01tNVl3ancyUFl2WjZ1OXNOZVZhdExwV1lfMmlBWFV1d05lTnQtc1lHTzdsdEU5b3BVRjFKU3BUQTRwZUNsNnpZdnpUVm55cDJaZVUwckhLQzNCVjhVZF9KeFFR?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-30T04:27:39+00:00", "published_display": "30 Jun 2026 04:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma Stock - analyst consensus and technical picture on a quiet news day", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxOeEQtMXM5VUQyaGNxVkppZTRBS1ptUTlHVjRhY2JabGhfejQ4TTY1cUpNMnJ6aEo1S0VDZVF1a3c3VDVUd1NaOWNLMGxNOHVjRXlfd2Zkb0tyaExHSkxxT0JvSDJIVzBlS2x0MndrcTBzLU1vMTJKTDFFNVFDc0pQWE1pOXNucGpITG5CSFdRdlpseEhiU09uSzF2Q2JUOEk4MEF2QW9nVUppZzJpdjEtN1RlemRCT3FIN3pXZ1ZUaWVfbnZvUU1n?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-06-18T20:53:13+00:00", "published_display": "18 Jun 2026 20:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun secures rights to Aribio\u2019s AR-1001 in potential $4.7B deal", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPVDdlMzFlMjA2VHJHVFgwa1puTDJCWE1mY3ZiWXlCbnlvRm4xVXVzUTFBOFJkcUVLWnZTOEtNUGdCZmJLOGVmR3lCRld5cGF1ZjdNWlNudE9tOFc1RTRmakRkZ2ZHWXdVcnhFamc2WFBlUTF5WkVuNHBqTnFtc3R2NXhSSkg3TlFRa0RMbGhyV1dOdTZPQmtDSnVUMzk1UDg2QUJxNw?oc=5", "source_name": "BioWorld News", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxNSVdiamVsSDVJVGxVckFWV09xTFBjSE1KTFJwdDFUVThXUjZHczFBQ1d4Z3FhOGZCTXY2SjhacEpvQVlOMHdpQWxsZlE1VHdRWVB1TGJETHpOLWVQWHBUcmJsVXZ5WTRKc20tWkp6NnlXdGRyZUpOZERMZ013Y0ljdUNLMG9LOU0waVQ0LVRiX1oyVmlqT2xvRHp6RHV5Z0lCV09QUVp2NGllaEFydEFpMWh5TThLcl9iNy16ZEdONVNCdVliam9vdUJBek1wcDJ0NmNPSFZDTjhkZHo3QmtBUDdSakNLQVZC?oc=5", "source_name": "BioSpace", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Fosun Pharma eyes spin-off Hong Kong IPO of vaccine unit", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma Inks Deal to Revive Botched China Alzheimer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPeHhraXd4RzZOUG9kNXg0YTRtNHFtNi1ROEN3T01LNDRwbXBJYXlJZEphUWFIaUFTRnN1VWhTV3JQTVhUMW1mbU5LTERCZFVZWFBqVW04UkN4alNPXzI5VjMzNVFtT0QwVHRtYlVZMkxHVVVGNTZwWjQtMHRLbWVyRkVXMzFIaTR3VlF1X3FBUDh4ZENyclJtVDFjSHBwNDZXUUFnMGM0U2hYRHAzSUE?oc=5", "source_name": "Bloomberg.com", "published_at": "2025-12-15T08:00:00+00:00", "published_display": "15 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun out-licenses phase II DPP-1 to newco Expedition for $645M", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2V0VElQcHUtUGpnSl9rcF9NSXRTNURjclVVa2VSZ0dnM2ZJNzU5WFViSHpmaTU1SjViakQteFR2Q1ZjSFNMY2JKWENkcDY3UmtnMWFUR2VEenNzaFltUEctaFdHOXJpQl92VHc4WG0xS1oya2JVTm9PN0twUE9Nd25CLVpXeS1WZVhkV0tYS1gtUFNPS1NGODI5OEROS25xcnJZV3B3?oc=5", "source_name": "BioWorld News", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Henlius Biotech shareholders reject take-private offer from China's Fosun", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxNQzNvVGlEUTRheEp4RGFvTUdkYzI0ZmRhUUZJRFV5TFlxV1dFSkt3a2d0NWZwRTRCd0ZTcjZTVG1CNUE1NHZCSkJtSFVVUmcwY2QwaTNOcVZPRExBeW9sanhrT2RHZ0hUcldhU1pYRlNXRGplWjlZSGVzN2RvR0dZU0hkLW14Z1VRcVFCLURqUE11LXlvOWZTTXBld29XUnZubDdkLW5BYzVBVWxEejJFYVR0U1BzWmJ3VXVGa1FTMDNTZ0JrQzlmX2NXbGlGYURWZDJWaWFn?oc=5", "source_name": "Reuters", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun's proposed Henlius Biotech buyout fails to pass shareholder vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZDI0dVRmVGtRMVNlMHJDNWRaSThwejRYWnFjc3NSUExjZmJLc3JYTFhtdmNXd2xocTRPS1lJdEIzenJVTHF3VFhWTlNaSml3NmxneDlkd0FUdGtVeHUzZ2hMMDhaTld5YjhsbURZRkVPUGpVTEJndjc0Uk5ydXptbTYtMDdMVl9KeTgzSE00M1VxTzRqZXAzalBwajdFUlBKLUF0Mzk5eXNXYjlwVlE?oc=5", "source_name": "Fierce Pharma", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma Offers $692 Million to Privatize Innovative Drugmaker Henlius", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPSUNURDBHckp3T0toMWtUMHNURE5zNHBzWS1ZQ3J5YjdmeFlFNWVLNkZxbDhJekFDaTlQTHBrWEhRQUdUdzZYTXVCbE9XOGQ1ZTBoSENaUldBd1pkWThCaVAtMEpmZklwaHo2a29lemdBNHlHSVAtQ28xakxDcnZIQW5KLTBQREh6QXpQZUJ0Q0hIaG56SGpobTdsOFM1eVRzUmlCZFlGSklSYWRIYjdINU5SZG1DYTItN3hwMDc3S3pNNG1WZTZN?oc=5", "source_name": "Caixin Global", "published_at": "2024-06-26T07:00:00+00:00", "published_display": "26 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Pharma soars after Beijing accepts application for vaccine trial", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPT2FvckFhZjJlR2Q3dF9keHREcmNUTkRmRUtFWThQbnhkUW5ieVdTMjM3Q1MyUzA1YlhYblJHUGZucGluUm82Q2otUE12aXpnazEzdjRCamxCU2NWRWVrdmg2U09mYUtMeUdvNkNQZXNJdG9HOXhQT3ZVUEFLbXl4WFpyZWl5M2JYNnMzXzhkUEdRdU1lRjFmZUh1eC1NMXIwZDNNOXpkTWo1NDdnc0QtR1JydmZFWlB20gG4AUFVX3lxTE5Ub2piZDJHV2l4blZzN2VMUDM1N0EySXdLVTBDTmhGc0hBcEFsQ21ZdmlRY0dSaEhjR3ZlcGx1eDZvakR5SXdCb1NZMnZLbGozQXJYQ3RaRnFkYW1mcUY5cnJYX3Y2ZnIzQjhwVE9lQ240UV9BREljYjVHekFDZkM0aEplN1k3LVNLeXJfejItVlgyV0xTeHRCRnNOTmRVcGVzUkhyYjBxTDNPYk9FXzgydTNTUVg4alU?oc=5", "source_name": "South China Morning Post", "published_at": "2020-07-14T07:00:00+00:00", "published_display": "14 Jul 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China approves its first biosimilar, a Rituxan copy from Fosun\u2019s IPO-heading Henlius", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPTFQ3aVQzRUlKanlLMjFLU3o4ZkpOaTJhLTk0VnVZVy1RN2hOQmJNNTZGcjE3X3cwNlcyOC00VEhJaHplOGVNNXZMajF6U1ItQWR1SHR2emdWMFFPbUZzZUhTbDhmVzFaRVJkaGZuNmJhVUxZNE5OVUM5V05PSlZGWklSLWJ0LVhiWVhRczJKREVSR3lQbUpBRUhxbG5SRnh2V1lkX29ObUNjdHFrNWtXaDZWcjlETnNQSExrR1N4SQ?oc=5", "source_name": "Fierce Pharma", "published_at": "2019-02-25T08:00:00+00:00", "published_display": "25 Feb 2019 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China\u2019s Fosun Pharma to buy French drug distributor Tridem", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "South China Morning Post", "published_at": "2017-10-30T07:00:00+00:00", "published_display": "30 Oct 2017 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China's Fosun, Shanghai Pharma say bid for stake in U.S. drug maker Arbor", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxORE1nRWEzS2x4U29fX3NVZWMwN1R2dURrY0JvbWNMTkgzUzdFSVFqNll6SmhoV2ZpMGkwV01raXE3LWtaWkluSV84cjF3VDExLXY0bXowM1VyV29DX0xITEdnTUV2VmJ3eXZsTlJzQUZtTkpubWJ4QkJxb2duaGF6M19tcGZwQTlFVjRoZnNhOUR0YVd1Q1IyalpSTndVV0Q2NnQwZ3VPMFdBZ9IBrwFBVV95cUxOLWdybE1qQmNrazhvZEpfOEFCQVlTdVNmQ2cweU5KNzFTSy0tNEFXeTVnclNIcDNvc19NTjRhd1pGVlA4d2N1QTFwS0w3MmhPMDBMNGJMSktfTkFSclBrdVNyVklwTloxRnhDdkFqREp6LWEyVTF4Q1VYUi1RRlhNRmxEOEc1QTVvb2pEc2dFd0s1aVNWYUpPNl8xNzVuamVEQ1VqY2pmWEFJbnZhZWtR?oc=5", "source_name": "CNBC", "published_at": "2017-08-14T07:00:00+00:00", "published_display": "14 Aug 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun stock tumbles over rumors of chairman disappearance\u2014again", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxPMXI3UU11REFJcUhRVGl4TlF0QUJ1V2syeG9BdDdKRHpMWk11LXN5MER1RWN4S29CRUdxcndzRXdiOUp0TkI3a3V1OGdrS0NndnJJZHp3cllFWWF3VTNGaTdlNEVNeEJ2QTZXak1aQVZUVmNoNElhTHJpbXU0Q25lbHV3MThOemFHdnlmSDhuX2tKdFRhTjJfNzVLcVBfaWVWeVJz?oc=5", "source_name": "Fierce Pharma", "published_at": "2017-07-07T07:00:00+00:00", "published_display": "07 Jul 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fosun Group attempts to explain as high-profile chief detained by China authorities", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMDdBcFNMMklROEgxSEFLN0dPMld4Y1ctTFoxbDh5SnFCaWxOUjJCVUhONHMxNDBXbXJaR0luRVdzVnZhWFZ6MmZJTTh1V1NROFNqdFhFZ3RENVE5Z1pNc1F1MXh1MGVYNDJmVVRNdVBIdi14QWN0SEYtWC1mNExIUlpLTklIaW9JNmF4QXIzZDM1NUpuNGRCUHd1czlqc0lCa2lydmhobHFRNzVWS09CZGw0ajhUZ3VKTWpITV9oN2Q?oc=5", "source_name": "Fierce Pharma", "published_at": "2015-12-14T08:00:00+00:00", "published_display": "14 Dec 2015 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chindex To Merge With Fosun Pharma At Higher Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPUzcyVTFNMmVaQkNoRERUSHV5dUJBTHN0Q0FQZ1N5cGZfS1VfX0pDbGpETGc1NEFHSm84Q1RBT3k4NGQ3S25vcmV2eG92QjNfdG1mYmxmQ1FyUG1UQXd6SnhhRG80Y0FXLWl3MGxudkFBODFDdVljc2ZJUWxhRHF4NW5tOEtHTzdZRlc1QUhuQ3hSSldKR3gxU1FCeHo3UQ?oc=5", "source_name": "Asian Scientist Magazine", "published_at": "2014-05-05T07:00:00+00:00", "published_display": "05 May 2014 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 60, "total_relevant": 20, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 18, "score": 51, "total": 20, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 7.5, "count": 13}, {"event": "deals", "label": "Deals and strategy", "weight": 2.35, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 23.4, "latest_week": "2026-07-17", "one_week_move": -0.2, "four_week_move": 7.4, "twelve_week_move": -7.8, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.29542, "market_dynamics_buy_signal": false, "relative_strength": -7.823663, "fair_value_gap": -7.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.9749, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.2% over one week, +7.4% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Fierce Pharma", "count": 4}, {"label": "Ad-hoc-news.de", "count": 3}, {"label": "South China Morning Post", "count": 3}, {"label": "\u5bcc\u9014\u725b\u725b", "count": 2}, {"label": "BioWorld News", "count": 2}, {"label": "BioSpace", "count": 1}, {"label": "Bloomberg.com", "count": 1}, {"label": "Reuters", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 20}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Deals and strategy", "count": 3}, {"label": "Earnings", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "20", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.2% over one week, +7.4% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Fosun Pharma stock holds firm as revenue grows and R&D spending rises"}], "updated_at": "2026-07-22T09:42:21.064340+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}